InsidersTradesSigma
Follow the ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B - H Shares stock price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares trade on HK HK, under the supervision of HKEX. Market capitalisation: €177.2m. The latest transaction was filed on 20 May 2026 (Other). Among the most active insiders: Tian Wenzhi. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. is a biopharmaceutical company focused on developing immunological treatments for cancer. It is listed under the H Shares category.